Intravenous Dabigatran for Anticoagulation during Cardiopulmonary Bypass in a Sheep Model
This study demonstrates that dabigatran effectively provides anticoagulation in a sheep CPB model, and idarucizumab successfully reverses its effects.
Authors
- Yang Gu (ORCID: https://orcid.org/0000-0001-6984-3653)
- Dana LeMoine (ORCID: https://orcid.org/0000-0002-4911-918X)
- Michael P. Eaton (ORCID: https://orcid.org/0000-0002-3705-9933)
- Ronald E. Angona
- Nathan Darrow
- Michael F. Swartz (ORCID: https://orcid.org/0000-0002-8477-8666)
- Karen Jones (ORCID: https://orcid.org/0000-0003-0667-210X)
- Brian J. Anderson (ORCID: https://orcid.org/0000-0002-2826-3019)
- Sergiy M. Nadtochiy (ORCID: https://orcid.org/0000-0003-2637-2075)
- Leslie F. Major
- Tatsiana Stefanos
- Changyong Feng (ORCID: https://orcid.org/0009-0000-6616-1745)
Institutions
- University of Auckland (NZ)
- SUNY Upstate Medical University (US)
- University of Rochester (US)
Publication Details
- Journal
- Anesthesiology
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1097/aln.0000000000005580
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.78